Severe Acute Respiratory News and Research

RSS

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

People’s belief in COVID-19-related conspiracy theories (CTs) In Europe.

27 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

Researchers highlight the limitations and challenges of using AI models for diagnosing COVID-19 from chest X-rays shared via smartphones. The study introduces a new multi-task learning model to improve diagnostic accuracy, addressing issues like prediction instability and faulty focus areas in images.

25 Oct 2023

NF-κB activation during COVID-19 and its impact on patients with hypertension

Researchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

Community immunity: Steering the evolutionary course of SARS-CoV-2

Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.

24 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

24 Oct 2023

Weakened innate immunity may increase risk of severe COVID-19

During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection.

24 Oct 2023

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

The decline in neutralizing antibody (nAb) titers following COVID-19 vaccination.

24 Oct 2023

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

A single-dose intranasal vaccine effectively induces robust immune responses.

24 Oct 2023

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Healthcare utilization by long coronavirus disease (COVID) or LC patients between January 2020 and 2023.

24 Oct 2023

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

Research paper evaluates the mental health impacts of the first COVID-19 wave on U.K. residents, revealing heightened psychological distress particularly among younger people, women, and minority groups. Factors such as financial stress, loneliness, and household density were found to significantly influence the severity of mental health decline during the pandemic.

23 Oct 2023

The transmission dynamics of SARS-CoV-2 among healthcare workers

The transmission of SARS-CoV-2 in hospitals and its impact on the dynamics of the COVID-19 pandemic.

23 Oct 2023

Severe Acute Respiratory News and Research

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

NF-κB activation during COVID-19 and its impact on patients with hypertension

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Community immunity: Steering the evolutionary course of SARS-CoV-2

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Weakened innate immunity may increase risk of severe COVID-19

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Is COVID-19 a risk factor for Alzheimer's disease?

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

The transmission dynamics of SARS-CoV-2 among healthcare workers

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News